Tag: halozyme therapeutics
HALO Gearing Up For A Rebound In 2013?
Investors holding shares of biotech Halozyme Therapeutics (HALO) awoke to excellent news Friday morning. The company announced it had entered into a worldwide collaboration and licensing agreement with Pfizer (PFE). The deal gives Pfizer a global license to develop and market products using Halozyme’s revolutionary Enhanze drug delivery technology. I’ll tell you all about this […]
